← Metformin × all-cause mortality

SynthesisMedicine2016

Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.

Xing-Kang He et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 2016

Range includes no effect

No clear effect on deaths

0.7×0.6× to 81×

Bigger than 8 in 10 for all-cause mortality

As reported

HR 0.68, 95% CI 0.58–81.0 · the paper's word: All-cause mortality

One number in the abstract

the abstract, start to end

… CRC patients compared to nonusers (HR = 0.68, 95% CI: 0.58-081).

← favours treatmentfavours comparator →
could be chance
All-cause mortality
HR 0.680.58–81.0
MetforminAll-cause mortality

Metformin × all-cause mortalityhelps?no deciding trial

unlikelylikely
0.25not counted
1 / 4

34 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26886616